UT-MD Anderson Cancer Center: New Combination Improves Radiation Therapy Outcomes in Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer
November 29, 2023
November 29, 2023
HOUSTON, Texas, Nov. 29 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Method sensitizes tumors to higher doses of stereotactic body radiation therapy without increasing toxicity
* * *
First author Cullen Taniguchi, M.D., Ph.D., passed away suddenly before the final publication of this study. A talented physician-scientist motivated by the impact of cancer on his own family, Taniguchi wa . . .
* * *
Method sensitizes tumors to higher doses of stereotactic body radiation therapy without increasing toxicity
* * *
First author Cullen Taniguchi, M.D., Ph.D., passed away suddenly before the final publication of this study. A talented physician-scientist motivated by the impact of cancer on his own family, Taniguchi wa . . .